back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2021-03-11 18:34 Tx date 2021-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-1,962,341.43
-59,519 vol $32.97 each |
256,853 | |
| Filed 2021-03-11 18:33 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+19,889 vol |
316,372 | |
| Filed 2021-03-11 18:32 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+99,842 vol |
296,483 | |
| Filed 2021-03-11 18:32 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-19,889 vol |
129,765 | |
| Filed 2021-03-11 18:30 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-99,842 vol |
76,276 | |
| Filed 2021-03-05 18:59 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+46,138 vol |
176,118 | |
| Filed 2021-03-05 18:58 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+91,684 vol |
1,552,360 | |
| Filed 2021-03-05 18:57 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+63,439 vol |
149,654 | |
| Filed 2021-03-03 20:37 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-495,022.10
-15,755 vol $31.42 each |
196,641 | |
| Filed 2021-03-03 20:36 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,319,074
+41,982 vol $31.42 each |
212,396 | |
| Filed 2021-03-03 20:35 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-41,982 vol |
86,215 | |
| Filed 2020-09-16 19:13 Tx date 2020-09-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-26,124.22
-1,642 vol $15.91 each |
170,414 | |
| Filed 2020-09-16 19:12 Tx date 2020-09-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$53,028
+3,333 vol $15.91 each |
172,056 | |
| Filed 2020-09-16 19:12 Tx date 2020-09-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-3,333 vol |
128,197 | |
| Filed 2020-03-12 10:30 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-195,514.88
-9,328 vol $20.96 each |
168,723 | |
| Filed 2020-03-12 10:30 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$416,873
+19,889 vol $20.96 each |
178,051 | |
| Filed 2020-03-12 10:26 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-416,873.44
-19,889 vol $20.96 each |
131,530 | |
| Filed 2020-03-11 17:18 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-175,161.48
-7,167 vol $24.44 each |
158,162 | |
| Filed 2020-03-11 17:17 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$512,531
+20,971 vol $24.44 each |
165,329 | |
| Filed 2020-03-11 17:17 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-512,531.24
-20,971 vol $24.44 each |
151,419 | |
| Filed 2020-03-11 16:38 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+25,212 vol |
129,980 | |
| Filed 2020-03-11 16:38 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+25,212 vol |
104,768 | |
| Filed 2020-03-11 16:37 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+159,192 vol |
1,460,676 | |
| Filed 2020-03-11 16:35 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+63,030 vol |
172,390 | |
| Filed 2019-09-23 10:44 Tx date 2019-09-16 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-38,160.08
-1,642 vol $23.24 each |
144,358 | |
| Filed 2019-09-23 10:43 Tx date 2019-09-16 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$77,458
+3,333 vol $23.24 each |
146,000 | |
| Filed 2019-09-23 10:42 Tx date 2019-09-16 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-3,333 vol |
109,360 | |
| Filed 2019-08-27 17:59 Tx date 2019-08-23 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-551,600
-24,625 vol $22.40 each |
142,667 | |
| Filed 2019-08-27 17:58 Tx date 2019-08-23 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,120,000
+50,000 vol $22.40 each |
167,292 | |
| Filed 2019-08-27 17:57 Tx date 2019-08-23 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-50,000 vol |
112,693 | |
| Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-468,584.84
-19,889 vol $23.56 each |
162,693 | |
| Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$468,584
+19,889 vol $23.56 each |
127,088 | |
| Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-230,793.76
-9,796 vol $23.56 each |
117,292 | |
| Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+124,002 vol |
1,301,484 | |
| Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+62,915 vol |
182,582 | |
| Filed 2018-09-18 Tx date 2018-09-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+10,000 vol |
119,667 | |
| Filed 2018-09-18 Tx date 2018-09-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$226,100
+10,000 vol $22.61 each |
107,199 | |
| Filed 2018-08-27 Tx date 2018-08-23 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-50,000 vol |
109,667 | |
| Filed 2018-08-27 Tx date 2018-08-23 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-550,883.62
-24,626 vol $22.37 each |
97,199 | |
| Filed 2018-08-27 Tx date 2018-08-23 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,118,500
+50,000 vol $22.37 each |
121,825 | |
| Filed 2018-03-14 Tx date 2018-03-13 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$241,469
+15,000 vol $16.10 each |
71,825 | |
| Filed 2018-03-14 Tx date 2018-03-07 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+59,667 vol |
159,667 | |
| Filed 2018-03-14 Tx date 2018-03-07 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+79,556 vol |
79,556 | |
| Filed 2018-03-14 Tx date 2016-08-22 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-14 Tx date 2018-03-07 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,719,024
+177,482 vol $15.32 each |
1,177,482 | |
| Filed 2017-08-25 Tx date 2017-08-23 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-707,000
-50,000 vol $14.14 each |
100,000 | |
| Filed 2017-08-25 Tx date 2017-08-23 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-242,854.50
-17,175 vol $14.14 each |
56,825 | |
| Filed 2017-08-25 Tx date 2017-08-23 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$707,000
+50,000 vol $14.14 each |
74,000 | |
| Filed 2017-03-18 Tx date 2017-03-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$257,280
+24,000 vol $10.72 each |
24,000 | |
| Filed 2017-03-18 Tx date 2016-08-22 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-09-02 Tx date 2016-08-22 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$4,311,000
+150,000 vol $28.74 each |
150,000 | |
| Filed 2016-09-02 Tx date 2016-08-22 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-09-02 Tx date 2016-08-22 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,000,000 | |
| Filed 2016-09-02 Tx date 2016-08-22 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|